LCM
NVS icon

Laurion Capital Management’s Novartis NVS Stock Holding History

Laurion Capital Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-5,357
Closed -$414K – 1324
2018
Q3 		$414K Buy
+5,357
New +$396K ﹤0.01% 871

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Laurion Capital Management's NVS Position: Q4 2018 in Review

Laurion Capital Management sold out of Novartis (NVS) in Q4 2018, closing a stake of 5,357 shares — an estimated $414K sold.

Laurion Capital Management first reported a position in NVS in Q3 2018 and held it in 1 quarter. The position peaked at $414K in Q3 2018. 1,087 funds tracked by Wall St. Rank hold NVS as of Q4 2018.

  • Laurion Capital Management reported no remaining Novartis position as of Q4 2018 after selling out during the quarter.
  • Laurion Capital Management sold 5,357 Novartis shares in Q4 2018, an estimated $414K.
  • Laurion Capital Management first reported a position in Novartis in Q3 2018 and held it in 1 quarter.
  • Laurion Capital Management's Novartis position peaked at $414K in Q3 2018.
  • 1,087 funds tracked by Wall St. Rank held Novartis as of Q4 2018.

Based on Laurion Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.